Blog Index
The journal that this archive was targeting has been deleted. Please update your configuration.

FAQS > General > How and why should U.S. manufacturing standards for ADJUVANTS be changed?

Search the FAQ for entries containing:

In order to ensure proper safety, the USDA should consider

1) requiring animal vaccine related ADJUVANTS to be manufactured in accordance with GMPs,
2) classifying animal vaccine related ADJUVANTS as Active Pharmaceutical Ingredients (APIs), and
3) regulating animal vaccine related ADJUVANTS like any other active ingredient in a pharmaceutical product. Making these changes would ensure that the same quality ADJUVANT is used in the production of agricultural and human vaccines.  A population’s overall health is, after all, based on many factors, including the people with whom we interact, the animal-based products we consume, and our co-existence with domestic pets in the home (zoonotic consideration). 

Consistent vaccine quality would enhance safety in each of these areas.

Last updated on October 10, 2012 by Sergeant Adjuvants

Content